A new complex rearrangement involving the ETV6, LOC115548, and MN1 in a of acute myeloid leukemia

Genes Chromosomes and Cancer

Volumn 41, Issue 3, 2004, Pages 272-277

  Belloni, Elena ^a,b   Trubia, Waurizio ^a,b   Mancini, Marco ^c   Derme, Valentina ^c   Nanni, Mauro ^c   Lahortiga, Idoya ^d   Riccioni, Roberta ^a,b,g   Confalonieri, Stefano ^a   Lo Coco, Francesco ^e   Di Fiore, Pier Paolo ^a,b,f   Pelicci, Pier Giuseppe ^a,b,f  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF NAVARRA   (Spain)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 5; CHROMOSOME BAND; ETV6 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DISRUPTION; GENE FUNCTION; GENE INSERTION; GENE REARRANGEMENT; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LOC115548 GENE; MNI GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; BASE SEQUENCE; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 5; DNA-BINDING PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MODELS, GENETIC; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSLOCATION, GENETIC;

INSERTION SEQUENCES;

EID: 4644295010     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20081     Document Type: Article

References (29)

1. Aspenstrom P. 1997. A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton. Curr Biol 7:479-487.
2. Baens M, Peeters P, Guo C, Aerssens J, Marynen P. 1996. Genomic organization of TEL: the human ETS-variant gene 6. Genome Res 6:404-413.
3. Bernard OA, Romana SP, Poirel H, Berger R. 1996. Molecular cytogenetics of t(12;21)(p13;q22). Leuk Lymphoma 23:459-465.
4. Bohlander SK. 2000. Fusion genes in leukemia: an emerging network. Cytogenet Cell Genet 91:52-56.
5. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, Grosveld G. 1995. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10:1511-1519.
6. Buijs A, van Rompaey L, Molijn AC, Davis JN, Vertegaal AC, Potter MD, Adams C, van Baal S, Zwarthoff EC, Roussel MF, Grosveld GC. 2000. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol 20:9281-9293.
7. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annal Biochem 162:156-159.
8. Cools J, Mentens N, Odero MD, Peeters P, Wlodarska I, Delforge M, Hagemeijer A, Marynen P. 2002. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13). Blood 99:1776-1784.
9. Frohling S, Skelin S, Liebisch C, Scholl C, Schlenk RF, Dohner H, Dohner K; Acute Myeloid Leukemia Study Group, Ulm. 2002. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. J Clin Oncol 20:2480-2485.
10. Fujita H, Katoh H, Ishikawa Y, Mori K, Negishi M. 2002. Rapostlin is a novel effector of Rnd2 GTPase inducing neurite branching. J Biol Chem 277:45428-45434.
11. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG. 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 92:4917-4921.
12. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG. 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107-4116.
13. Gréer P. 2002. Closing in on the biological functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol 3:278-289.
14. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. 1998. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92:2322-2333.
15. Lekanne Deprez RH, Riegman PH, Groen NA, Warringa UL, van Biezen NA, Molijn AC, Bootsma D, de Jong PJ, Menon AG, Kiev NA, Seizinger BR, Zwarthoff EC. 1995. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 10:1521-1528.
16. Mrozek K, Heinonen K, de la Chapelle A, Bloomfield CD. 1997. Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 24:17-31.
17. Mrozek K, Heinonen K, Bloomfield CD. 2001. Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol 14:19-47.
18. Odero MD, Carlson K, Calasanz MJ, Lahortiga I, Chinwalla V, Rowley JD. 2001. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 31:134-142.
19. Poirel H, Lacronique V, Mauchauffe M, Le Coniat M, Raffoux E, Daniel MT, Erickson P, Drabkin H, MacLeod RA, Drexler HG, Ghysdael J, Berger R, Bernard OA. 1998. Analysis of TEL proteins in human leukemias. Oncogene 16:2895-2903.
20. Rawat VP, Cusan M, Deshpande A, Hiddemann W, Quintanilla-Martinez L, Humphries RK, Bohlander SK, Feuring-Buske M, Buske C. 2004. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia. Proc Natl Acad Sci USA 101:817-822.
21. Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B. 1996. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891-2899.
22. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. 1995. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662-3670.
23. Rowley JD. 1999. The role of chromosome translocations in leukemogenesis. Semin Hematol 36:59-72.
24. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, Roy DC, Busqué L, Kurnit D, VVillman C, Gewirtz AM, Speck NA, Bushweller JH, Li FP, Gardiner K, Poncz M, Maris JM, Gilliland DG. 1999. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23:166-175.
25. Storlazzi CT, Specchia G, Anelli L, Albano F, Pastore D, Zagaria A, Rocchi M, Liso V. 2002. Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients. Genes Chromosomes Cancer 35:271-276.
26. Takahashi S, Inatome R, Hotta A, Qin Q, Hackenmiller R, Simon MC, Yamamura H, Yanagi S. 2003. Role for Fes/Fps tyrosine kinase in microtubule nucleation through is Fes/CIP4 homology domain. J Biol Chem 278:49129-49133.
27. Tian L, Nelson DL, Stewart DM. 2000. Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules. J Biol Chem 275:7854-7861.
28. van Wely KH, Molijn AC, Buijs A, Meester-Smoor MA, Aarnoudse AJ, Hellemons A, den Besten P, Grosveld GC, Zwarthoff EC. 2003. The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription. Oncogene 22:699-709.
29. Wlodarska I, Mecucci C, Baens M, Marynen P, van den Berghe H. 1996. ETV6 gene rearrangements in hematopoietic malignant disorders. Leuk Lymphoma 23:287-295.